Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and respiratory diseases. The Company’s lead candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of life-threatening infections including community-aquired bacterial pneumonia and biodefense pathogens including anthrax, plague and tularemia.
| Date | Title | | 05/20/11 | Advanced Life Sciences Cancels Annual Meeting of Shareholders| CHICAGO, May 20, 2011 /PRNewswire via COMTEX/ -- Advanced Life Sciences Holdings, Inc. (OTCBB: ADLS.OB), announced today that it has cancelled its Annual Meeting of Shareholders, which was previously scheduled to take place on Tuesday, May 24, 2011.
(Logo: http://photos.prnewswire.com/prnh/20080218/ALSLOGO)
About Advanced Life Sciences
Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas o... |
| | 05/05/11 | Advanced Life Sciences Suspends Operations| CHICAGO, May 5, 2011 /PRNewswire via COMTEX/ -- Advanced Life Sciences Holdings, Inc. (OTCBB: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has suspended operations and terminated its staff due to its severe lack of liquidity.
(Logo: http://photos.prnewswire.com/prnh/20080218/ALSLOGO)
"We presently do not have sufficient cash to f... |
| | 04/27/11 | Advanced Life Sciences Ticker Symbol Reverts Back to 'ADLS.OB'| CHICAGO, April 27, 2011 /PRNewswire via COMTEX/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS.OB), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced that as of today the Company's ticker symbol has reverted back to "ADLS.OB." Over the past 20 business days, the ticker symbol had a "D" temporarily appended to it indicating a recent reverse s... |
|
|
More >>
There are currently no upcoming events
Annual Report & Proxy
Investor Fact Sheet
E-mail Alerts
Follow Us on Twitter
